Inspired by the effect that miR-134-5p induced ferroptosis through inhibiting GPX4, we designed a nanocarrier (PCC-R8-ROS, Scheme 1) to deliver miR-134-5p inhibitor for BPD theranostic applications efficiently. This evidence concerns the gene GPX4 and bronchopulmonary dysplasia.